Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Age (Dordr) ; 38(3): 51, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27106271

ABSTRACT

Mild cognitive impairment (aMCI) is a clinical condition, with high risk to develop Alzheimer's disease. Physical exercise may have positive effect on cognition and brain structure in older adults. However, it is still under research whether these influences are true on aMCI subjects with low Ab_42 and high total tau in cerebrospinal fluid (CSF), which is considered a biomarker for AD. Therefore, we aimed to investigate a possible relation between aerobic fitness (AF) and gray matter (GM) volume and AF and white matter (WM) integrity in aMCI with a CSF biomarker. Twenty-two participants with aMCI acquired the images on a 3.0-T MRI. AF was assessed by a graded exercise test on a treadmill. Voxel-based morphometry and tract-based spatial statistic methods were used to analyze the GM volume and WM microstructural integrity, respectively. We correlated AF and GM volume and WM integrity in aMCI (p < 0.05, FWE corrected, cluster with at least five voxels). There was a positive relation between AF and GM volume mostly in frontal superior cortex. In WM integrity, AF was positively correlated with fractional anisotropy and negatively correlated with mean diffusivity and radial diffusivity, all in the same tracts that interconnect frontal, temporal, parietal, and occipital areas (longitudinal fasciculus, fronto-occipital fasciculus, and corpus callosum). These results suggest that aerobic fitness may have a positive influence on protection of brain even in aMCI CSF biomarker, a high-risk population to convert to AD.


Subject(s)
Aging/physiology , Brain/diagnostic imaging , Cognitive Dysfunction/rehabilitation , Corpus Callosum/diagnostic imaging , Exercise Therapy/methods , Physical Fitness/physiology , Aged , Aged, 80 and over , Anisotropy , Brain/physiopathology , Cognitive Dysfunction/diagnosis , Cognitive Dysfunction/physiopathology , Corpus Callosum/physiopathology , Female , Humans , Magnetic Resonance Imaging/methods , Male , Middle Aged , Neuropsychological Tests
2.
Horm Behav ; 65(3): 195-202, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24472740

ABSTRACT

Corticotropin-releasing factor (CRF) plays a critical role in the mediation of physiological and behavioral responses to stressors. In the present study, we investigated the role played by the CRF system within the medial amygdala (MeA) in the modulation of anxiety and fear-related responses. Male Wistar rats were bilaterally administered into the MeA with CRF (125 and 250 ng/0.2µl, experiment 1) or with the CRFR1 antagonist antalarmin (25 ng/0.2 µl, experiment 2) and 10 min later tested in the elevated T-maze (ETM) for inhibitory avoidance and escape measurements. In clinical terms, these responses have been respectively related to generalized anxiety and panic disorder. To further verify if the anxiogenic effects of CRF were mediated by CRFR1 activation, we also investigated the effects of the combined treatment with CRF (250 ng/0.2 µl) and antalarmin (25 ng/0.2 µl) (experiment 3). All animals were tested in an open field, immediately after the ETM, for locomotor activity assessment. Results showed that CRF, in the two doses administered, facilitated ETM avoidance, an anxiogenic response. Antalarmin significantly decreased avoidance latencies, an anxiolytic effect, and was able to counteract the anxiogenic effects of CRF. None of the compounds administered altered escape responses or locomotor activity measurements. These results suggest that CRF in the MeA exerts anxiogenic effects by activating type 1 receptors, which might be of relevance to the physiopathology of generalized anxiety disorder.


Subject(s)
Behavior, Animal/drug effects , Corticomedial Nuclear Complex/drug effects , Corticotropin-Releasing Hormone/pharmacology , Pyrimidines/pharmacology , Pyrroles/pharmacology , Receptors, Corticotropin-Releasing Hormone/physiology , Animals , Avoidance Learning/drug effects , Corticomedial Nuclear Complex/pathology , Corticomedial Nuclear Complex/surgery , Corticotropin-Releasing Hormone/administration & dosage , Inhibition, Psychological , Male , Maze Learning/drug effects , Motor Activity/drug effects , Pyrimidines/administration & dosage , Pyrroles/administration & dosage , Rats , Rats, Wistar , Receptors, Corticotropin-Releasing Hormone/antagonists & inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL
...